Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus

• Published in: Current pharmaceutical design Vol. 25; no. 18; p. 2051
• Main Authors: Katsiki, Niki, Anagnostis, Panagiotis, Kotsa, Kalliopi, Goulis, Dimitrios G, Mikhailidis, Dimitri P
• Format: Journal Article
• Language: English
• Published: United Arab Emirates 01.01.2019
• Subjects: Cardiovascular Diseases - complications; Diabetes Mellitus, Type 2 - complications; Humans; Metabolic Syndrome - complications; Non-alcoholic Fatty Liver Disease - complications; Obesity - complications; Risk Factors; diabetic kidney disease; metabolic syndrome; Obesity; diabetic peripheral neuropathy; non-alcoholic fatty liver disease; diabetic retinopathy

Obesity frequently co-exists with type 2 diabetes mellitus (T2DM), leading to the socalled "diabesity epidemic". The metabolic syndrome (MetS), a cluster of central obesity, hypertension, dysglycemia, insulin resistance and/or atherogenic dyslipidemia, as well as non-alcoholic fatty liver...